EUVIMEDEUVIMED entdecken
Crossref

Elevated Trimethylamine‐N‐oxide (TMAO) Is Associated with Vascular Access Dysfunction in Maintenance Hemodialysis Patients

Yin Zheng iD, Yuan Ren, Li You, Junfeng Liu, Jun Xue

Hemodialysis International · 2025

DOI: 10.1111/hdi.13255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemodialysis International, 2025. Verfasst von Yin Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Methylamines, Renal Dialysis, Vascular Access Devices. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Elevated levels of trimethylamine‐ N ‐oxide (TMAO), a metabolite produced by gut microbiota, have been associated with cardiovascular diseases and complications in various populations. However, its role in vascular access dysfunction in hemodialysis patients remains underexplored. This study investigates the potential relationship between TMAO levels and vascular access dysfunction in maintenance hemodialysis patients.

Methods

This study included 80 hemodialysis patients. The baseline serum TMAO levels were measured, and clinical characteristics and dialysis‐related data were collected. They were followed up on vascular access dysfunction events over a period of 1 year. The association between serum TMAO levels and vascular access dysfunction events were investigated.

Findings

In our cohort, we observed a wide distribution of serum concentrations, with a median concentration of 15.2 μmol/L and a maximum concentration of 245.3 μmol/L. Patients were stratified into a low‐TMAO group and a high‐TMAO group according to the median value of TMAO concentrations. Those in the high‐TMAO group had a significantly higher incidence of vascular access dysfunction events ( p = 0.023). TMAO was independently associated with vascular access dysfunction events after adjusting for some potential vascular access dysfunction risk factors.

Discussion

This study suggests that elevated serum TMAO levels may serve as an independent risk factor for vascular access dysfunction in hemodialysis patients. Reducing TMAO levels may potentially decrease the incidence of vascular access dysfunction, warranting further investigation into this therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesRenal DialysisVascular Access DevicesHumansMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

chronic kidney diseasehemodialysistrimethylamine‐N‐oxidevascular access dysfunction

Substanzen

Methylaminestrimethyloxamine

Autor:innen und Institutionen

  • Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Yin Zheng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zheng, Y., Ren, Y., You, L., Liu, J., & Xue, J. (2025). Elevated Trimethylamine‐N‐oxide (TMAO) Is Associated with Vascular Access Dysfunction in Maintenance Hemodialysis Patients. Hemodialysis International. https://doi.org/10.1111/hdi.13255

Vancouver

Zheng Y, Ren Y, You L, Liu J, Xue J. Elevated Trimethylamine‐N‐oxide (TMAO) Is Associated with Vascular Access Dysfunction in Maintenance Hemodialysis Patients. Hemodialysis International. 2025. doi:10.1111/hdi.13255

BibTeX
@article{Zheng2025,
  author = {Zheng, Yin and Ren, Yuan and You, Li and Liu, Junfeng and Xue, Jun},
  title = {Elevated Trimethylamine‐N‐oxide (TMAO) Is Associated with Vascular Access Dysfunction in Maintenance Hemodialysis Patients},
  journal = {Hemodialysis International},
  year = {2025},
  doi = {10.1111/hdi.13255}
}
Kostenlos starten →